| - | Alzheimer’s Disease: Early Diagnosis & Fundamental Therapeutics | Kim Youngsoo |
| - | Amyloidogenesis targeting small molecule as a drug candidate | Kim Youngsoo; BYEON SEONG RIM; Kim Hye Yun; LEE JI HOON; Hwang Hana; Cho JeiWon; Young-Gil Ahn; Young Hoon Kim; Maeng Sup Kim; Gwan Sun Lee; Inhee Mook-Jung; Kim, Dong Jin |
| - | Biological tactics to control in vitro beta-amyloid aggregation | Kim Hye Yun; Kim Youngsoo; Kim, Dong Jin |
| - | Biological tactics to control in vitro beta-amyloid aggregation for Alzheimer's disease | Kim Hye Yun; Kim Youngsoo; Kim, Dong Jin |
| - | Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for beta-amyloid fibril formation | Kim Youngsoo; BYEON SEONG RIM; Kim Hye Yun; LEE JI HOON; Ji-Hoon Sohn; Inhee Mook-Jung; Kim, Dong Jin |
| - | Correlations of amyloid-b levels between CSF and plasma in acute AD mouse mode | Cho Soo Min; Kim, Hyunjin; Lee Sejin; Kim Hye Yun; Kim Woong; Kim, Tae Song; Kim, Dong Jin; Kim Youngsoo |
| - | Dihydroisoindolone derivatives as potential PET imaging agents for detection of beta-amyloid fibrils | LEE JI HOON; Soo Jeong Lim; Sang Joo Lim; Kim Youngsoo; Seung Jun Oh; Dae Hyuk Moon; Yoo, Kyung Ho; Kim, Dong Jin |
| - | Disaggregation of b-amyloid plaques by KMSB600 | Kim HyeYun; Kim Youngsoo; GyoonHee Han; Kim, Dong Jin |
| - | Disaggregation of β-amyloid Fibrils in vitro by KMSB600 | Kim Hye Yun; M.J. Kim; Kim Youngsoo; Kim, Dong Jin |
| - | Efficient access to highly pure beta-amyloid by optimized solid-phase synthesis | Choi Ji won; Kim Hye Yun; Jeon Mijin; Kim, Dong Jin; Kim Youngsoo |
| - | Flamma Fluors™, Fluorescent Probes for Molecular Imaging | Park Jin Woo; Kim Youngsoo; Jong Joo Na; Kim, Dong Jin |
| - | Fluorescent Cyanine Labeling Reagents for Molecular Imaging | Kim Youngsoo; Park Jin Woo; Hwang Hana; Jong Joo Na; Kim, Dong Jin |
| - | Fluoroisoindolone Derivatives as Potential PET Imaging Agents for Detection of beta-amyloid Fibrils | Choi Jiyeon; Kim Youngsoo; LEE JI HOON; Soo Jeong Lim; Seung Jun Oh; Dae Hyuk Moon; Kim, Dong Jin |
| - | Fundamental therapeutics and early diagnostic probes targeting neurotoxic beta-amyloid species for Alzheimer's disease | Kim Youngsoo |
| - | Fundamental therapeutics and early diagnostic probes targeting neurotoxic β-amyloid species for Alzheimer's disease | Kim Youngsoo |
| - | KMS88009 and KMS88016 as small molecule inhibitors for in vivo Ab fibril formation | Kim Youngsoo; Byun, Ji Hun; Ryu Jiyeon; Hwang Hana; LEE JI HOON; Cho JeiWon; Kim HyeYun; Young-Gil Ahn; Young Hoon Kim; Maeng Sup Kim; Gwan Sun Lee; Inhee Mook-Jung; Yoo, Kyung Ho; Kim, Dong Jin |
| 2012-03 | Pathology of Neurodegenerative Diseases | Kim Youngsoo; Kim, Yun Kyung; 황온유; Kim, Dong Jin |
| - | Potential PET Imaging Agents for Early Diagnosis of Alzheimer’s Disease | Kim Youngsoo; Kim, Dong Jin |
| - | Pyrazolopyrimidine and sulforaphane derivatives as candidates with antioxidant-inducing effects for Parkinson disease therapeutics | Kim Youngsoo; Cheong, Chan Seong; NAM, GHILSOO; Choi, Kyung Il; Yoo, Kyung Ho; O. Hwang; Kim, Dong Jin |
| - | Selective generation of neurotoxic β-amyloid species induced by controlled amyloidogenesis | Jeon Mijin; Kim Hye Yun; Kim Hyun Jin; Kim Min Jung; Choi Ji won; 송문정; Kim, Dong Jin; Kim Youngsoo |
| - | Synergistic neuroprotective effect of KMSB600 and donepezil in the Alzheimer's disease animal model | Kim, Hyunjin; Kim Hye Yun; Kim, Dong Jin; Kim Youngsoo |
| - | Syntheses of biologically active and covalently bonded amyloid-b dimers | Lee Sejin; Kim Hye Yun; Kim Youngsoo |
| - | Synthesis and Evaluation of Styrylisoxazole Derivatives with High Affinity β-Amyloid Protein | Lee Myoung-hwan; Park Jin Woo; Kim Youngsoo; Bong Young Chung; Kim, Dong Jin |
| - | Synthetic b-amyloid dimer in anti-parallel conformaiton induces in vivo synaptic plasticity deficits | Kim Hye Yun; Kim, Hyunjin; Lee Sejin; Kim, Dong Jin; Kim Youngsoo |
